Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hisako Yoshida"'
Autor:
Yuichi Akasaki, Kenya Kusunose, Kazuo Eguchi, Hirotsugu Yamada, Masataka Sata, Prize Study Investigators, Yoshihiro Fukumoto, Haruo Kamiya, Hiroki Teragawa, Koichi Node, Atsushi Tanaka, Kazuomi Kario, Hisako Yoshida
Publikováno v:
Hypertension Research
Hyperuricemia is related to an increased risk of cardiovascular events from a meta-analysis and antihyperuricemia agents may influence to cardiac function. We evaluated the effect of febuxostat on echocardiographic parameters of diastolic function in
Autor:
Yutaka Furukawa, Hideko Toyama, Yasuhiro Sasaki, Yoshitaro Matsumoto, Atsushi Kobori, Koichiro Kumagai, Ayumi Shintani, Hisako Yoshida
Publikováno v:
Japanese Journal of Electrocardiology. 40:158-166
Autor:
Takashi Juri, Takashi Mori, Aya Kimura, Koichi Suehiro, Yohei Fujimoto, Hisako Yoshida, Kiyonobu Nishikawa, Katsuaki Tanaka
Publikováno v:
Anesthesia and analgesia. 133(1)
BACKGROUND We aimed to evaluate the ability of lung recruitment maneuver-induced hemodynamic changes to predict fluid responsiveness in patients undergoing lung-protective ventilation during one-lung ventilation (OLV). METHODS Thirty patients undergo
Autor:
Kohei Kaku, Koichi Node, Mamoru Nanasato, Koji Maemura, Makoto Saito, Jun-ichi Oyama, Ryoji Ishiki, Hisako Yoshida, Teruo Inoue, Masayoshi Ajioka, Yukihito Higashi, Atsushi Tanaka, Tomoko Ishizu, Toyoaki Murohara, Yoshisato Shibata
Publikováno v:
International Journal of Cardiology. 271:331-335
Background Whether a dipeptidyl peptidase-4 (DPP-4) inhibitor can attenuate atherosclerosis is still controversial. Some clinical trials reported that DPP-4 inhibitors in diabetes patients without a previous history of cardiovascular (CV) events coul
Autor:
Takeshi Kato, Toyoaki Murohara, Nobutaka Kitamura, Yoshihiro Morino, Masafumi Watanabe, Kazuomi Kario, Hisako Yoshida, Kenji Ando, Empa-Icd investigators, Yoshifusa Aizawa, Hirofumi Tomita, Kenichi Iijima, Shigeto Naito, Masafumi Yano, Toshihisa Anzai, Koji Maemura, Keiko Ota, Yusuke Kondo, Koichi Node, Kazuyoshi Takahashi, Yasuchika Takeishi, Ippei Shimizu, Masaaki Okabe, Takeshi Mitsuhashi, Hiroshi Tada, Kenichi Tsujita, Nobuhisa Hagiwara, Daisuke Izumi, Junichi Nitta, Masaki Ieda, Shinya Fujiki, Wataru Shimizu, Shinichi Niwano, Yoshihisa Nakagawa, Kazuyuki Ozaki, Kengo Kusano, Takahiro Tanaka, Takeshi Kimura, Tetsuji Miura, Tohru Minamino, Ritsushi Kato
Publikováno v:
Diabetes Therapy
Introduction Type 2 diabetes (T2DM) is associated with cardiovascular death, including sudden cardiac death due to arrhythmias. Patients with an implantable cardioverter-defibrillator (ICD) are also at high risk of developing a clinically significant
Autor:
Takayo Murase, Masaaki Inaba, Takashi Nakamura, Masanori Emoto, Shinya Fukumoto, Shio Yoshida, Hisako Yoshida, Masafumi Kurajoh, Kazuto Hirata
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Xanthine oxidoreductase (XOR) inhibitor administration reduces uric acid and reactive oxygen species (ROS) production, and also lowers blood pressure (BP). However, the associations of plasma XOR activity, uric acid level, and oxidative stress levels
Autor:
Hisako Yoshida, Shunsuke Yamada, Masatomo Taniguchi, Toshiaki Nakano, Kazuhiko Tsuruya, Masanori Tokumoto, Takanari Kitazono, Ryusuke Yotsueda, Hokuto Arase
Publikováno v:
Atherosclerosis. 275:115-123
Background and aims The modified creatinine (Cr) index, calculated by age, sex, pre-dialysis serum Cr levels, and Kt/V for urea, reflects skeletal muscle mass in patients on hemodialysis. Whether the modified Cr index is associated with cardiovascula
Autor:
Makoto Hirakawa, Koji Mitsuiki, Hidetoshi Kanai, Masaharu Nagata, Kazuhiko Tsuruya, Yusuke Kuroki, Takashi Yoshiura, Hisako Yoshida, Takanari Kitazono, Tohru Mizumasa, Hideki Hirakata, Kei Hori
Publikováno v:
American Journal of Kidney Diseases. 65:312-321
Background Brain atrophy has been reported in patients with end-stage renal disease receiving hemodialysis, although its mechanism is unknown. However, little is known regarding brain atrophy in patients receiving peritoneal dialysis (PD). Therefore,
Autor:
Hirotsugu Yamada, Atsushi Tanaka, Kenya Kusunose, Rie Amano, Munehide Matsuhisa, Hiroyuki Daida, Masaaki Ito, Hiroyuki Tsutsui, Mamoru Nanasato, Haruo Kamiya, Yasuko K. Bando, Masato Odawara, Hisako Yoshida, Toyoaki Murohara, Masataka Sata, Koichi Node, for the PROLOGUE Study Investigators
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-12 (2017)
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-12 (2017)
Background Diabetes is associated closely with an increased risk of cardiovascular events, including diastolic dysfunction and heart failure that leads to a shortening of life expectancy. It is therefore extremely valuable to evaluate the impact of a
Autor:
Kiichiro Fujisaki, Takanari Kitazono, Hideki Hirakata, Kazuhiko Tsuruya, Hisako Yoshida, Naoki Haruyama
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0143706 (2015)
PLoS ONE, Vol 10, Iss 12, p e0143706 (2015)
Background & Objectives It is well known that cognitive impairment in patients with chronic kidney disease (CKD) is characterized by executive dysfunction, rather than memory dysfunction, although the precise mechanism of this remains to be elucidate